Altarex Corp.
Records under this name other than patents Altarex Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Altarex Corp.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,147,850 | Therapeutic Binding Agents Against MUC-1 Antigen and Methods for Their Use Formerly held Term ended Ended no later than Oct 13, 2021 · Low confidence | Term ended | Ended no later than Oct 13, 2021 | Low confidence |
| US 6,689,355 | Therapeutic Method and Composition Utilizing Antigen-Antibody Complexation and Presentation by Dendritic Cells Formerly held Term ended Term ended May 11, 2021 · High confidence | Term ended | Term ended May 11, 2021 | High confidence |
| US 6,716,966 | Therapeutic binding agents against MUC-1 antigen and methods for their use Formerly held Term ended Term ended Aug 18, 2020 · From the USPTO record | Term ended | Term ended Aug 18, 2020 | From the USPTO record |
| US 7,579,445 | Reagents and methods for inducing an immune response to prostate specific antigen Formerly held Term ended Term ended Jan 4, 2020 · From the USPTO record | Term ended | Term ended Jan 4, 2020 | From the USPTO record |
| US 6,881,405 | Reagents and methods for inducing an immune response to prostate specific antigen Formerly held Term ended Term ended Jun 15, 2019 · From the USPTO record | Term ended | Term ended Jun 15, 2019 | From the USPTO record |
| US 6,241,985 | Method and composition for reconforming multi-epitopic antigens to initiate an immune response Formerly held Term ended Term ended Mar 20, 2018 · From the USPTO record | Term ended | Term ended Mar 20, 2018 | From the USPTO record |
| US 6,086,873 | Therapeutic composition and method of treatment Formerly held Term ended Term ended Jun 17, 2017 · From the USPTO record | Term ended | Term ended Jun 17, 2017 | From the USPTO record |
| US 7,318,921 | Therapeutic compositions that alter the immune response Formerly held Term ended Ended no later than May 15, 2016 · From the USPTO record | Term ended | Ended no later than May 15, 2016 | From the USPTO record |
| US 7,361,346 | Therapeutic compositions that produce an immune response Formerly held Term ended Ended no later than May 15, 2016 · From the USPTO record | Term ended | Ended no later than May 15, 2016 | From the USPTO record |